Lorena Fernández de la Cruz

Lorena Fernández de la Cruz

Auto-generated profile, based on publicly available information

Lorena Fernández de la Cruz

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2018 in JAMA
Verified
Journal Article
Open access
PDF file
HSHuanlu Song
Huanlu Song
FFFang Fang
Fang Fang
GTGunnar Tomasson
Gunnar Tomasson
FAFilip K. Arnberg
Filip K. Arnberg
DMDavid Mataix-Cols
David Mataix-Cols
UVUnnur A. Valdimarsdóttir
Unnur A. Valdimarsdóttir
Most humans are at some point during their lives exposed to trauma or significant life stressors, including loss of loved ones and exposure to various disasters or violence.1,2 While many individuals exposed to such adversities gradually recover,1,3 a significant proportion goes on to develop severe psychiatric reactions, including posttraumatic stress disorder (PTSD) or acute stress reaction (also known as acute stress disorder) after life-threatening events,4 or adjustment disorder triggered by an identifiable and stressful life change.5 Individuals with such stress-related disorders experience an array of physiologic alterations, including disruption of the hypothalamic-pituitary-adrenal axis6 and autonomic nervous system,6,7 which in turn may influence multiple bodily systems, eg, immune function,6,8 and thereby susceptibility to disease.

1 February 2016 in World Psychiatry
Verified
Journal Article
Closed access
PDF file
DMDavid Mataix‐Cols
David Mataix‐Cols
LCLorena Fernández de la Cruz
Lorena Fernández de la Cruz
ANAshley E. Nordsletten
Ashley E. Nordsletten
FLFabian Lenhard
Fabian Lenhard
KIKayoko Isomura
Kayoko Isomura
HSHelen Blair Simpson
Helen Blair Simpson

1 May 2017 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
DMDavid Mataix-Cols
David Mataix-Cols
LCLorena Fernández de la Cruz
Lorena Fernández de la Cruz
BMBenedetta Monzani
Benedetta Monzani
DRDavid Rosenfield
David Rosenfield
EAErik Andersson
Erik Andersson
PTPaul Thuras
Paul Thuras
Anxiety, obsessive-compulsive, and posttraumatic stress disorders constitute the most prevalent group of mental disorders, collectively affecting up to 30% of individuals at some point in their lives.1 These conditions contribute significantly to the global burden of disease and disability-adjusted life-years.2

1 December 2019 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
MTMiquel Tortella-Feliu
Miquel Tortella-Feliu
MFMiquel A. Fullana
Miquel A. Fullana
APAna Pérez-Vigil
Ana Pérez-Vigil
XTXavier Torres
Xavier Torres
JCJacobo Chamorro
Jacobo Chamorro
LCLorena Fernández de la Cruz
Lorena Fernández de la Cruz

1 August 2016 in Clinical Psychology Review
Verified
Journal Article
Open access
AHAmy Harrison
Amy Harrison
LCLorena Fernández de la Cruz
Lorena Fernández de la Cruz
JEJesper Enander
Jesper Enander
Joaquim RaduàJoaquim Raduà
Joaquim Raduà
DMDavid Mataix-Cols
David Mataix-Cols
Body dysmorphic disorder (BDD) is a chronic and disabling psychiatric disorder unlikely to remit without treatment. A systematic review and meta-analysis of randomized controlled trials (RCTs) of cognitive-behavioral therapy (CBT) for BDD was conducted, including published and unpublished trials to 26th November 2015. Primary outcomes were validated BDD measures; secondary outcomes included depression and insight. Meta-regressions were conducted to examine potential effects of variables on the primary outcome, including socio-demographic variables, comorbidity, symptom severity/duration, concomitant medication, treatment duration, and methodological quality of the RCTs. Seven RCTs (N=299) met inclusion criteria. CBT was superior to waitlist or credible psychological placebo in reducing BDD (7 studies; delta=-1.22, 95% CI=-1.66 to -0.79) and depression symptoms (5 studies; delta=-0.49, 95% CI=-0.76 to -0.22). CBT was associated with improvements in insight/delusionality (4 studies; delta=-0.56, 95% CI=-0.93 to -0.19). Improvement in BDD was maintained after 2-4months follow-up (3 studies; delta=-0.89, 95% CI=-1.24 to -0.54). Meta-regression analyses did not reveal any significant predictors of outcome. CBT is an efficacious treatment for BDD but there is substantial room for improvement. The specificity and long-term effects of CBT for BDD require further evaluation using credible control conditions. Additional trials comparing CBT with pharmacological therapies, as well as their combination, are warranted. Tele-care options, such as Internet-based CBT, hold great promise to increase access to evidence-based treatment for a majority of patients who need it and should be evaluated further.

2 August 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
TZTianyang Zhang
Tianyang Zhang
ASAnna Sidorchuk
Anna Sidorchuk
LSLaura Sevilla-Cermeño
Laura Sevilla-Cermeño
AVAlba Vilaplana-Pérez
Alba Vilaplana-Pérez
ZCZheng Chang
Zheng Chang
LCLorena Fernández de la Cruz
Lorena Fernández de la Cruz
Cesarean delivery can effectively reduce maternal and neonatal mortality and morbidity in the presence of complications, such as antepartum hemorrhage, fetal distress, abnormal fetal presentation, and hypertensive disease.1 During the past 3 decades, worldwide cesarean delivery rates have seen a more than 3-fold increase, from approximately 6% in 1990 to 21% in 2015, with substantial variations among and within countries.1 There is no precise information on appropriate cesarean delivery rates at the population level, although the international health care community considers 10% to 15% to be an optimal rate.2 Public health concerns have been raised because access to medically indicated cesarean delivery may be difficult in low-resource settings and unnecessary cesarean deliveries may be performed in high-resource settings.1,3,4